Patents by Inventor Solvi Gunnes

Solvi Gunnes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10711040
    Abstract: The present invention relates to novel low substituted polymyxins and compositions thereof.
    Type: Grant
    Filed: June 29, 2015
    Date of Patent: July 14, 2020
    Assignee: XELLIA PHARMACEUTICALS APS
    Inventors: Vidar Bjornstad, Solvi Gunnes, Torben Koch, Claes Melander
  • Patent number: 10640536
    Abstract: Disclosed herein is a composition comprising at least one polymyxin or a salt thereof represented by formula (I) wherein R1 is an aliphatic linear or branched C6-C10 acyl group, or (I?) R5 is —CH(CH3)2, —CH2CH(CH3)2, —CH(CH3)CH2CH3, or —CH2C6H5; R6 is —CH(CH3)2, —CH2CH(CH3)2, or —CH(CH3)CH2CH3; each of R2, R3, R4, R7 and R8 is either —(CH2)xCH2NH2 or —(CH2)xCH2N(CH2SO3M)2; wherein x is 0 or 1; wherein M is a monovalent cation; and wherein at least three of R2, R3, R4, R7 and R8 are —(CH2)xCH2N(CH2SO3M)2.
    Type: Grant
    Filed: January 9, 2014
    Date of Patent: May 5, 2020
    Assignee: XELLIA PHARMACEUTICALS APS
    Inventors: Solvi Gunnes, Vidar Bjornstad, Torben Koch, Claes Melander, Martin Mansson
  • Publication number: 20170218024
    Abstract: The present invention relates to novel low substituted polymyxins and compositions thereof.
    Type: Application
    Filed: June 29, 2015
    Publication date: August 3, 2017
    Inventors: VIDAR BJORNSTAD, SOLVI GUNNES, TORBEN KOCH, CLAES MELANDER
  • Publication number: 20160002296
    Abstract: Disclosed herein is a composition comprising at least one polymyxin or a salt thereof represented by formula (I) wherein R1 is an aliphatic linear or branched C6-C10 acyl group, or (I?) R5 is —CH(CH3)2, —CH2CH(CH3)2, —CH(CH3)CH2CH3, or —CH2C6H5; R6 is —CH(CH3)2, —CH2CH(CH3)2, or —CH(CH3)CH2CH3; each of R2, R3, R4, R7 and R8 is either —(CH2)XCH2NH2 or —(CH2)xCH2N(CH2SO3M)2; wherein x is 0 or 1; wherein M is a monovalent cation; and wherein at least three of R2, R3, R4, R7 and R are —(CH2)xCH2N(CH2SO3M)2.
    Type: Application
    Filed: January 9, 2014
    Publication date: January 7, 2016
    Inventors: SOLVI GUNNES, VIDAR BJORNSTAD, TORBEN KOCH, CLAES MELANDER, MARTIN MANSSON
  • Patent number: 8981055
    Abstract: The present invention relates to an improved process for the preparation of Micafungin.
    Type: Grant
    Filed: March 26, 2012
    Date of Patent: March 17, 2015
    Assignee: Xellia Pharmaceuticals APS
    Inventors: Solvi Gunnes, Harald Halvorsen
  • Publication number: 20140371422
    Abstract: The present invention relates to an improved process for the preparation of Micafungin.
    Type: Application
    Filed: March 26, 2012
    Publication date: December 18, 2014
    Applicant: Xellia Pharmaceuticals ApS
    Inventors: Solvi Gunnes, Harald Halvorsen
  • Patent number: 8076301
    Abstract: Disclosed herein are 10-desmethyl, 10 substituted-macrolides, their preparation, pharmaceutical compositions containing them, their use and methods of treatment using them. The 10-desmethyl macrolides are particularly useful as antibiotics.
    Type: Grant
    Filed: September 30, 2009
    Date of Patent: December 13, 2011
    Assignee: C10 Pharma AS
    Inventors: Kjell Undheim, Solvi Gunnes
  • Publication number: 20100137234
    Abstract: Disclosed herein are 10-desmethyl, 10 substituted-macrolides, their preparation, pharmaceutical compositions containing them, their use and methods of treatment using them. The 10-desmethyl macrolides are particularly useful as antibiotics.
    Type: Application
    Filed: September 30, 2009
    Publication date: June 3, 2010
    Applicant: C10 Pharma AS
    Inventors: Kjell Undheim, Solvi Gunnes
  • Patent number: 7608596
    Abstract: Disclosed herein are 10-desmethyl, 10 substituted-macrolides, their preparation, pharmaceutical compositions containing them, their use and methods of treatment using them. The 10-desmethyl macrolides are particularly useful as antibiotics.
    Type: Grant
    Filed: December 22, 2003
    Date of Patent: October 27, 2009
    Assignee: C10 Pharma AS
    Inventors: Kjell Undheim, Solvi Gunnes
  • Publication number: 20060241060
    Abstract: The invention provides antibiotic 10-desmethyl macrolides.
    Type: Application
    Filed: December 22, 2003
    Publication date: October 26, 2006
    Inventors: Kjell Undheim, Solvi Gunnes